Your browser doesn't support javascript.
loading
Comprehensive evaluation of the pharmacological and toxicological effects of γ-valerolactone as compared to γ-hydroxybutyric acid: Insights from in vivo and in silico models.
Arfè, Raffaella; Bilel, Sabrine; Tirri, Micaela; Corli, Giorgia; Bergamin, Eva; Serpelloni, Giovanni; Bassi, Marta; Borsari, Martina; Boccuto, Federica; Bernardi, Tatiana; Caruso, Lorenzo; Alkilany, Alaaldin M; Rachid, Ousama; Botrè, Francesco; De-Giorgio, Fabio; Marti, Matteo.
Afiliação
  • Arfè R; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
  • Bilel S; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
  • Tirri M; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
  • Corli G; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
  • Bergamin E; Università Cattolica del Sacro Cuore, Roma, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Serpelloni G; Neuroscience Clinical Center & TMS Unit, VR, Italy.
  • Bassi M; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
  • Borsari M; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
  • Boccuto F; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
  • Bernardi T; Department of Environmental Sciences and Prevention University of Ferrara, Ferrara, Italy.
  • Caruso L; Department of Environmental Sciences and Prevention University of Ferrara, Ferrara, Italy.
  • Alkilany AM; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Qatar.
  • Rachid O; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Qatar.
  • Botrè F; Antidoping Laboratory FMSI, Rome, Italy; REDs - Research and Expertise in antidoping Sciences, ISSUL - Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland.
  • De-Giorgio F; Università Cattolica del Sacro Cuore, Roma, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy. Electronic address: fabio.degiorgio@unicatt.it.
  • Marti M; Department of Translational Medicine, Section of Legal Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy; Collaborative Center for the Italian National Early Warning System, Department of Anti-Drug Policies, Presidency of the Council of Ministers, Italy. Electronic address: matteo.mart
Drug Alcohol Depend ; 252: 110951, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37717308

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxibato de Sódio Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxibato de Sódio Idioma: En Ano de publicação: 2023 Tipo de documento: Article